Saturday, March 18, 2017

Medispec and Li-Eswt

MediSpec products support medical device manufacturers by delivering the latest interconnect technologies for maximum product efficiency, trustworthiness and flexibility. MediSpec products address the electronic design demands of medical equipment manufacturers engineering new and emerging healthcare products in diagnostic imaging, therapeutic and surgical, patient monitoring, clinic and patient care and healthcare IT applications. The effectiveness and reliability of healthcare devices and systems rely on the strong design, engineering and performance of their underlying gadgets. With its Medispec stock portfolio of products, Molex is leading the way in the convergence of digital product integration into medical applications and delivering the technology solutions for the next generation of health care.

Low intensity shock influx remedy (Li-ESWT) is at the moment approved in 20+ countries and available at over 200 clinics worldwide. A US multicenter study is over and the data are currently under FDA review. Herein we offer an overview of the specialized medical experience to date on the protection and efficiency of Li-ESWT for the treatment of erectile malfunction. Studies were conducted in men with ED considered responders and in men considered poor responders to PDE5i. We report put data from 5 randomized, placebo-controlled studies (USA, His home country of israel, Greece and India) and 3 single-arm open sticker studies (Israel, Japan). Li-Eswt for ED has recently been recently included in the European Association of Urology guideline 2013 for individual sexual dysfunction.

No comments:

Post a Comment